CN103897072A - 一种金刚藤多糖提取物及其制备方法 - Google Patents
一种金刚藤多糖提取物及其制备方法 Download PDFInfo
- Publication number
- CN103897072A CN103897072A CN201310739491.7A CN201310739491A CN103897072A CN 103897072 A CN103897072 A CN 103897072A CN 201310739491 A CN201310739491 A CN 201310739491A CN 103897072 A CN103897072 A CN 103897072A
- Authority
- CN
- China
- Prior art keywords
- rhizome
- polysaccharide
- bock greenbrier
- water
- bock
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000004676 glycans Chemical class 0.000 title claims abstract description 174
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 159
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 159
- 240000009022 Smilax rotundifolia Species 0.000 title claims abstract description 138
- 235000003205 Smilax rotundifolia Nutrition 0.000 title claims abstract description 138
- 239000000284 extract Substances 0.000 title claims abstract description 57
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 238000000605 extraction Methods 0.000 title claims description 79
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 claims abstract description 36
- 210000004369 blood Anatomy 0.000 claims abstract description 32
- 239000008280 blood Substances 0.000 claims abstract description 32
- 230000017531 blood circulation Effects 0.000 claims abstract description 7
- 230000036039 immunity Effects 0.000 claims abstract description 7
- 230000002708 enhancing effect Effects 0.000 claims abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 126
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 97
- 238000001556 precipitation Methods 0.000 claims description 50
- 239000000463 material Substances 0.000 claims description 32
- 238000010992 reflux Methods 0.000 claims description 31
- 239000007788 liquid Substances 0.000 claims description 29
- 239000000203 mixture Substances 0.000 claims description 26
- 239000003814 drug Substances 0.000 claims description 24
- 229940079593 drug Drugs 0.000 claims description 20
- 239000002904 solvent Substances 0.000 claims description 20
- 238000011282 treatment Methods 0.000 claims description 19
- 239000006228 supernatant Substances 0.000 claims description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 9
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 8
- 239000003960 organic solvent Substances 0.000 claims description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 6
- 230000001737 promoting effect Effects 0.000 claims description 6
- 238000003809 water extraction Methods 0.000 claims description 5
- 238000005238 degreasing Methods 0.000 claims description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 3
- 239000012046 mixed solvent Substances 0.000 claims description 2
- 239000003921 oil Substances 0.000 claims description 2
- 239000002893 slag Substances 0.000 claims description 2
- 238000000638 solvent extraction Methods 0.000 claims description 2
- 230000004054 inflammatory process Effects 0.000 abstract description 18
- 206010061218 Inflammation Diseases 0.000 abstract description 17
- 238000011160 research Methods 0.000 abstract description 11
- 230000002349 favourable effect Effects 0.000 abstract description 3
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 230000003213 activating effect Effects 0.000 abstract 1
- 241000700159 Rattus Species 0.000 description 95
- 239000000243 solution Substances 0.000 description 82
- 235000019441 ethanol Nutrition 0.000 description 70
- 238000012360 testing method Methods 0.000 description 49
- 229930003944 flavone Natural products 0.000 description 45
- 235000011949 flavones Nutrition 0.000 description 45
- 210000004291 uterus Anatomy 0.000 description 44
- 210000002381 plasma Anatomy 0.000 description 42
- 238000000034 method Methods 0.000 description 35
- 239000000523 sample Substances 0.000 description 35
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N flavone Chemical group O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 30
- 238000010438 heat treatment Methods 0.000 description 29
- 150000002213 flavones Chemical class 0.000 description 27
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 23
- 108010002350 Interleukin-2 Proteins 0.000 description 19
- 102000000588 Interleukin-2 Human genes 0.000 description 19
- 210000004027 cell Anatomy 0.000 description 19
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 18
- 150000002212 flavone derivatives Chemical class 0.000 description 18
- 229940099472 immunoglobulin a Drugs 0.000 description 18
- 239000010410 layer Substances 0.000 description 17
- 229940027941 immunoglobulin g Drugs 0.000 description 16
- 102000018594 Tumour necrosis factor Human genes 0.000 description 15
- 108050007852 Tumour necrosis factor Proteins 0.000 description 15
- 230000006378 damage Effects 0.000 description 15
- 238000002474 experimental method Methods 0.000 description 15
- 150000004804 polysaccharides Polymers 0.000 description 15
- 239000003153 chemical reaction reagent Substances 0.000 description 14
- 230000001684 chronic effect Effects 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 238000004043 dyeing Methods 0.000 description 13
- 230000000694 effects Effects 0.000 description 13
- 102000004169 proteins and genes Human genes 0.000 description 13
- 108090000623 proteins and genes Proteins 0.000 description 13
- 238000000746 purification Methods 0.000 description 13
- 239000000843 powder Substances 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 11
- 239000002775 capsule Substances 0.000 description 11
- 238000001816 cooling Methods 0.000 description 11
- 238000005259 measurement Methods 0.000 description 11
- 239000011347 resin Substances 0.000 description 11
- 229920005989 resin Polymers 0.000 description 11
- 238000000926 separation method Methods 0.000 description 11
- 239000004568 cement Substances 0.000 description 10
- 201000010099 disease Diseases 0.000 description 10
- 230000008595 infiltration Effects 0.000 description 10
- 238000001764 infiltration Methods 0.000 description 10
- 230000007170 pathology Effects 0.000 description 10
- 235000008216 herbs Nutrition 0.000 description 9
- 230000001575 pathological effect Effects 0.000 description 9
- 230000008859 change Effects 0.000 description 8
- 239000000706 filtrate Substances 0.000 description 8
- 230000002757 inflammatory effect Effects 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 239000013558 reference substance Substances 0.000 description 8
- 230000000630 rising effect Effects 0.000 description 8
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 7
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 7
- 230000002159 abnormal effect Effects 0.000 description 7
- 230000001154 acute effect Effects 0.000 description 7
- 210000004907 gland Anatomy 0.000 description 7
- 206010020718 hyperplasia Diseases 0.000 description 7
- 239000005457 ice water Substances 0.000 description 7
- 210000004400 mucous membrane Anatomy 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 210000001744 T-lymphocyte Anatomy 0.000 description 6
- 239000003463 adsorbent Substances 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 210000002808 connective tissue Anatomy 0.000 description 6
- 210000000981 epithelium Anatomy 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 238000005304 joining Methods 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 5
- 102000003886 Glycoproteins Human genes 0.000 description 5
- 108090000288 Glycoproteins Proteins 0.000 description 5
- 108060003951 Immunoglobulin Proteins 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- YVNQAIFQFWTPLQ-UHFFFAOYSA-O [4-[[4-(4-ethoxyanilino)phenyl]-[4-[ethyl-[(3-sulfophenyl)methyl]amino]-2-methylphenyl]methylidene]-3-methylcyclohexa-2,5-dien-1-ylidene]-ethyl-[(3-sulfophenyl)methyl]azanium Chemical compound C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C(=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S(O)(=O)=O)C)C=2C(=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S(O)(=O)=O)C)C=C1 YVNQAIFQFWTPLQ-UHFFFAOYSA-O 0.000 description 5
- 102000011759 adducin Human genes 0.000 description 5
- 108010076723 adducin Proteins 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 5
- 102000018358 immunoglobulin Human genes 0.000 description 5
- 238000011068 loading method Methods 0.000 description 5
- 210000002751 lymph Anatomy 0.000 description 5
- 238000002203 pretreatment Methods 0.000 description 5
- 230000035755 proliferation Effects 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 230000009102 absorption Effects 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 230000006837 decompression Effects 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 4
- 102000004127 Cytokines Human genes 0.000 description 3
- 108090000695 Cytokines Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 208000002495 Uterine Neoplasms Diseases 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 208000037976 chronic inflammation Diseases 0.000 description 3
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 210000004696 endometrium Anatomy 0.000 description 3
- 210000002889 endothelial cell Anatomy 0.000 description 3
- 210000002919 epithelial cell Anatomy 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 210000001087 myotubule Anatomy 0.000 description 3
- 210000003101 oviduct Anatomy 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 206010046766 uterine cancer Diseases 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 206010020880 Hypertrophy Diseases 0.000 description 2
- 206010021703 Indifference Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 244000261559 Smilax china Species 0.000 description 2
- 235000000485 Smilax china Nutrition 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000000540 analysis of variance Methods 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000003305 autocrine Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000002146 bilateral effect Effects 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 230000005779 cell damage Effects 0.000 description 2
- 208000037887 cell injury Diseases 0.000 description 2
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 201000003511 ectopic pregnancy Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 description 2
- 229960001008 heparin sodium Drugs 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 230000003076 paracrine Effects 0.000 description 2
- 230000008807 pathological lesion Effects 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 239000002831 pharmacologic agent Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000004064 recycling Methods 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 238000000518 rheometry Methods 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- QGMRQYFBGABWDR-UHFFFAOYSA-N sodium;5-ethyl-5-pentan-2-yl-1,3-diazinane-2,4,6-trione Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)NC1=O QGMRQYFBGABWDR-UHFFFAOYSA-N 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 230000000451 tissue damage Effects 0.000 description 2
- 231100000827 tissue damage Toxicity 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 210000003556 vascular endothelial cell Anatomy 0.000 description 2
- BNGXYYYYKUGPPF-UHFFFAOYSA-M (3-methylphenyl)methyl-triphenylphosphanium;chloride Chemical compound [Cl-].CC1=CC=CC(C[P+](C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 BNGXYYYYKUGPPF-UHFFFAOYSA-M 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241000606153 Chlamydia trachomatis Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010015719 Exsanguination Diseases 0.000 description 1
- 206010016825 Flushing Diseases 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 108090001007 Interleukin-8 Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241000204048 Mycoplasma hominis Species 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010034240 Pelvic congestion Diseases 0.000 description 1
- 206010040070 Septic Shock Diseases 0.000 description 1
- 241001063882 Smilax moranensis Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000006374 Uterine Cervicitis Diseases 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- CKMXBZGNNVIXHC-UHFFFAOYSA-L ammonium magnesium phosphate hexahydrate Chemical compound [NH4+].O.O.O.O.O.O.[Mg+2].[O-]P([O-])([O-])=O CKMXBZGNNVIXHC-UHFFFAOYSA-L 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 230000007503 antigenic stimulation Effects 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000006472 autoimmune response Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 238000009954 braiding Methods 0.000 description 1
- 206010008323 cervicitis Diseases 0.000 description 1
- 239000007910 chewable tablet Substances 0.000 description 1
- 229940068682 chewable tablet Drugs 0.000 description 1
- 229940038705 chlamydia trachomatis Drugs 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002357 endometrial effect Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 108010074605 gamma-Globulins Proteins 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000007235 immunity generation Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000002434 immunopotentiative effect Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 210000004493 neutrocyte Anatomy 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 210000004303 peritoneum Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 235000019353 potassium silicate Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000036303 septic shock Effects 0.000 description 1
- 210000004999 sex organ Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 229910052567 struvite Inorganic materials 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310739491.7A CN103897072B (zh) | 2012-12-27 | 2013-12-27 | 一种金刚藤多糖提取物及其制备方法 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210578844.5 | 2012-12-27 | ||
CN2012105788445 | 2012-12-27 | ||
CN201210578844 | 2012-12-27 | ||
CN201310739491.7A CN103897072B (zh) | 2012-12-27 | 2013-12-27 | 一种金刚藤多糖提取物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103897072A true CN103897072A (zh) | 2014-07-02 |
CN103897072B CN103897072B (zh) | 2016-08-31 |
Family
ID=50985257
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310737797.9A Active CN103893473B (zh) | 2012-12-27 | 2013-12-27 | 一种治疗盆腔炎的药物组合物及其用途 |
CN201310739491.7A Active CN103897072B (zh) | 2012-12-27 | 2013-12-27 | 一种金刚藤多糖提取物及其制备方法 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310737797.9A Active CN103893473B (zh) | 2012-12-27 | 2013-12-27 | 一种治疗盆腔炎的药物组合物及其用途 |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN103893473B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104248732A (zh) * | 2013-06-27 | 2014-12-31 | 成都百草和济科技有限公司 | 一种金刚藤多糖提取物及其制备方法 |
CN110804106A (zh) * | 2018-08-06 | 2020-02-18 | 广东省中医院 | 一种土茯苓精制多糖及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101011545A (zh) * | 2007-02-09 | 2007-08-08 | 华中科技大学 | 一种制备菝葜有效部位群的方法 |
CN101468133A (zh) * | 2007-12-26 | 2009-07-01 | 北京卓越同创药物研究院 | 一种治疗妇科炎症的药物组合物 |
CN101703669A (zh) * | 2009-12-15 | 2010-05-12 | 湖北福人药业股份有限公司 | 菝葜有效部位群及其提取纯化工艺 |
KR101156636B1 (ko) * | 2010-12-01 | 2012-06-14 | 동국대학교 경주캠퍼스 산학협력단 | 청미래덩굴 추출물을 함유하는 혈관질환의 예방 또는 치료용 약학 조성물 |
CN102671059A (zh) * | 2011-03-17 | 2012-09-19 | 天津药物研究院 | 菝葜提取物及其制备方法与用途 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101480477A (zh) * | 2008-01-09 | 2009-07-15 | 怀化正好制药有限公司 | 一种治疗妇科炎症疾病的中药提取物及其制备方法 |
-
2013
- 2013-12-27 CN CN201310737797.9A patent/CN103893473B/zh active Active
- 2013-12-27 CN CN201310739491.7A patent/CN103897072B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101011545A (zh) * | 2007-02-09 | 2007-08-08 | 华中科技大学 | 一种制备菝葜有效部位群的方法 |
CN101468133A (zh) * | 2007-12-26 | 2009-07-01 | 北京卓越同创药物研究院 | 一种治疗妇科炎症的药物组合物 |
CN101703669A (zh) * | 2009-12-15 | 2010-05-12 | 湖北福人药业股份有限公司 | 菝葜有效部位群及其提取纯化工艺 |
KR101156636B1 (ko) * | 2010-12-01 | 2012-06-14 | 동국대학교 경주캠퍼스 산학협력단 | 청미래덩굴 추출물을 함유하는 혈관질환의 예방 또는 치료용 약학 조성물 |
CN102671059A (zh) * | 2011-03-17 | 2012-09-19 | 天津药物研究院 | 菝葜提取物及其制备方法与用途 |
Non-Patent Citations (3)
Title |
---|
刘俊彦等: ""黑刺菝葜根茎化学成分的研究"", 《西北农业大学学报》, vol. 28, no. 1, 29 February 2000 (2000-02-29), pages 105 - 108 * |
李苏翠等: ""菝葜根茎活性部位的抗炎作用及其对环氧化酶活性影响的研究"", 《亚太传统医药》, vol. 5, no. 7, 15 July 2009 (2009-07-15), pages 16 - 21 * |
田亚平等: "《生化分离原理与技术(第1版)》", 31 May 2010, 化学工业出版社, article "植物组织中多糖的提取", pages: 11 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104248732A (zh) * | 2013-06-27 | 2014-12-31 | 成都百草和济科技有限公司 | 一种金刚藤多糖提取物及其制备方法 |
CN104248732B (zh) * | 2013-06-27 | 2017-09-12 | 成都百草和济科技有限公司 | 一种金刚藤多糖提取物及其制备方法 |
CN110804106A (zh) * | 2018-08-06 | 2020-02-18 | 广东省中医院 | 一种土茯苓精制多糖及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103893473A (zh) | 2014-07-02 |
CN103893473B (zh) | 2017-11-28 |
CN103897072B (zh) | 2016-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101161251B (zh) | 续断总皂苷提取物及其提取方法和应用 | |
CN103550484A (zh) | 一种调节雌激素水平的药物组合物、其制备方法及用途 | |
CN102875690A (zh) | 一种抗卵巢功能衰退的中药多糖提取物、制备方法及用途 | |
CN1327876C (zh) | 治疗糖尿病及其并发症的中药组合物 | |
CN104127808B (zh) | 治疗恶性肿瘤的中药制剂及其制备方法 | |
CN103897072B (zh) | 一种金刚藤多糖提取物及其制备方法 | |
CN100381166C (zh) | 一种治疗慢性子宫颈炎的栓剂 | |
CN104173503A (zh) | 一种中药颗粒剂的制备方法及其制备的中药颗粒剂和用途 | |
CN106421208A (zh) | 一种具有抗化学性肝损伤功能的药物组合物及其制备方法 | |
CN103445176B (zh) | 增强免疫力保健食品及其制备方法 | |
CN103690768B (zh) | 麦冬参芪软胶囊及其制备方法 | |
CN101288762A (zh) | 一种治疗产后恶露不行的中药组合物及其制备方法和质量控制方法 | |
CN100362022C (zh) | 海螵蛸多糖cps-1及其制备方法和用途 | |
CN102133302A (zh) | 一种马鞭草中提取的治疗前列腺炎的马鞭草提取物 | |
CN109224038A (zh) | 一种治疗瘀血阻络型肝纤维化的含引经药吴茱萸的中药组合物及其制备方法和应用 | |
CN113509530B (zh) | 一种治疗哮喘的中药复方制剂及其制备工艺和质量控制方法 | |
CN105560308A (zh) | 金花葵花在制备用于预防和治疗前列腺疾病的产品中的应用 | |
CN103877448A (zh) | 金刚藤提取物及其制备方法 | |
CN102861192B (zh) | 用于慢性肾功能衰竭和腹膜纤维化的药物组合物 | |
CN104248732B (zh) | 一种金刚藤多糖提取物及其制备方法 | |
CN103877327A (zh) | 一种治疗肾病综合征的药物组合物及其制备方法和用途 | |
CN103655970A (zh) | 山楂泻籽软胶囊及其制备方法 | |
CN106511914A (zh) | 一种具有抗癌作用的中药组合物及其的新用途 | |
CN105998160A (zh) | 沙苑子总黄酮在制备治疗围绝经期抑郁症药物中的应用 | |
CN103830656B (zh) | 治疗盆腔炎的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160831 Address after: 610000 No. 29 Tian Xiao street, Chengdu, Sichuan, Wuhou District Patentee after: CHENGDU KEER PHARMACEUTICAL Co.,Ltd. Address before: 11, building 134, 610041 Xiaojiahe street, hi tech Zone, Sichuan, Chengdu, 1 Patentee before: CHENGDU LILI MEDICINE TECHNOLOGY CO.,LTD. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20180112 Address after: Wenjiang District 610000 of Sichuan city of Chengdu province Chengdu Strait science and Technology Industry Development Park Branch Road No. 188 West 1 floor of Building 2 Patentee after: Sichuan hundred Seiko Seiko Biotechnology Co.,Ltd. Address before: 610000 No. 29 Tian Xiao street, Chengdu, Sichuan, Wuhou District Patentee before: CHENGDU KEER PHARMACEUTICAL Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211027 Address after: 610000 No. 1314, floor 13, building 1, No. 1166, Tianfu Third Street, Chengdu hi tech Zone, China (Sichuan) pilot Free Trade Zone, Chengdu, Sichuan Patentee after: CHENGDU BAICAO HEJI TECHNOLOGY Co.,Ltd. Address before: 2 / F, building 1, No. 188, west section of Kexing Road, Chengdu cross strait science and Technology Industrial Development Park, Wenjiang District, Chengdu, Sichuan 610000 Patentee before: Sichuan hundred Seiko Seiko Biotechnology Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220629 Address after: Building 2, No. 168, Huangqin Road, Zhihe street, Pengzhou, Chengdu, Sichuan 610000 Patentee after: Sichuan Tianfu fragrant health Technology Research Institute Co.,Ltd. Address before: 610000 No. 1314, floor 13, building 1, No. 1166, Tianfu Third Street, Chengdu hi tech Zone, China (Sichuan) pilot Free Trade Zone, Chengdu, Sichuan Patentee before: CHENGDU BAICAO HEJI TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right |